These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5309475)

  • 21. MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications.
    Baldo V; Baldovin T; Floreani A; Carraro AM; Trivello R;
    Vaccine; 2007 May; 25(20):3955-61. PubMed ID: 17383057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)].
    Bruj J; Skocil V; Farník J; Hronovský F; Síp J
    Cesk Epidemiol Mikrobiol Imunol; 1981 Sep; 30(5):287-93. PubMed ID: 6456837
    [No Abstract]   [Full Text] [Related]  

  • 23. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibody response to trivalent anti-influenza vaccination (inactivated virus) A/Texas/1/77 H3N2), A/URSS/90/77 (H1N1), B/Hong Kong/8/73].
    Mancini G; Andreoni M; Arangio-Ruiz G; Sarrecchia C; Donatelli I; Resta S; Rozera C; Sordillo P; Rocchi G
    Boll Ist Sieroter Milan; 1982 May; 61(2):85-91. PubMed ID: 7126342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69.
    Glezen WP; Loda FA; Denny FW
    Bull World Health Organ; 1969; 41(3):566-9. PubMed ID: 5309478
    [No Abstract]   [Full Text] [Related]  

  • 27. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection.
    O'Hagan DT
    Expert Rev Vaccines; 2007 Oct; 6(5):699-710. PubMed ID: 17931151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza pandemics, immune cross-reactivity, and pandemic control strategies.
    Gioia C; Agrati C; Castilletti C; Capobianchi MR; Martini F
    J Infect Dis; 2008 Jul; 198(2):294-5; author reply 295-6. PubMed ID: 18593297
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies of the 1996-1997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness.
    Hurwitz ES; Haber M; Chang A; Shope T; Teo ST; Giesick JS; Ginsberg MM; Cox NJ
    J Infect Dis; 2000 Oct; 182(4):1218-21. PubMed ID: 10979921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influenza vaccination: NOW!].
    Heinzl S
    Med Monatsschr Pharm; 2006 Nov; 29(11):389. PubMed ID: 17131684
    [No Abstract]   [Full Text] [Related]  

  • 31. From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza.
    Wood JM; Robertson JS
    Nat Rev Microbiol; 2004 Oct; 2(10):842-7. PubMed ID: 15378048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Problems in the control of epidemic influenza by vaccination.
    Pereira MS
    Ann Clin Res; 1982 Dec; 14(5-6):220-4. PubMed ID: 7171231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccines: the virosome concept.
    Wilschut J
    Immunol Lett; 2009 Feb; 122(2):118-21. PubMed ID: 19100779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New vaccine for flu season.
    FDA Consum; 2005; 39(6):2. PubMed ID: 16669107
    [No Abstract]   [Full Text] [Related]  

  • 36. Pre- or post-pandemic influenza vaccine?
    Osterhaus AD
    Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is pandemic influenza possible, probable, or confirmed?].
    Hamon-Mekki F
    Soins; 2009 Sep; (738):1. PubMed ID: 19824143
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
    Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
    Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
    [No Abstract]   [Full Text] [Related]  

  • 39. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.
    Lipatov AS; Hoffmann E; Salomon R; Yen HL; Webster RG
    J Infect Dis; 2006 Oct; 194(8):1040-3. PubMed ID: 16991078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccines in the prevention of viral pneumonia.
    Betts RF
    Semin Respir Infect; 1995 Dec; 10(4):282-7. PubMed ID: 8668856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.